Cargando…

Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines

Detalles Bibliográficos
Autores principales: Leong, Meredith, Kanne, David, Glickman, Laura, Lemmens, Edward, Lauer, Peter, Metchette, Ken, Burdette, Dara, Diner, Elie, Fu, Juan, Soares, Kevin, Brockstedt, Dirk, Portnoy, Daniel, Vance, Russell, Kim, Young, Jaffee, Elizabeth, Pardoll, Drew, Dubensky, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990975/
http://dx.doi.org/10.1186/2051-1426-1-S1-O20
_version_ 1782312357371838464
author Leong, Meredith
Kanne, David
Glickman, Laura
Lemmens, Edward
Lauer, Peter
Metchette, Ken
Burdette, Dara
Diner, Elie
Fu, Juan
Soares, Kevin
Brockstedt, Dirk
Portnoy, Daniel
Vance, Russell
Kim, Young
Jaffee, Elizabeth
Pardoll, Drew
Dubensky, Thomas
author_facet Leong, Meredith
Kanne, David
Glickman, Laura
Lemmens, Edward
Lauer, Peter
Metchette, Ken
Burdette, Dara
Diner, Elie
Fu, Juan
Soares, Kevin
Brockstedt, Dirk
Portnoy, Daniel
Vance, Russell
Kim, Young
Jaffee, Elizabeth
Pardoll, Drew
Dubensky, Thomas
author_sort Leong, Meredith
collection PubMed
description
format Online
Article
Text
id pubmed-3990975
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39909752014-05-01 Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines Leong, Meredith Kanne, David Glickman, Laura Lemmens, Edward Lauer, Peter Metchette, Ken Burdette, Dara Diner, Elie Fu, Juan Soares, Kevin Brockstedt, Dirk Portnoy, Daniel Vance, Russell Kim, Young Jaffee, Elizabeth Pardoll, Drew Dubensky, Thomas J Immunother Cancer Oral Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990975/ http://dx.doi.org/10.1186/2051-1426-1-S1-O20 Text en Copyright © 2013 Leong et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Leong, Meredith
Kanne, David
Glickman, Laura
Lemmens, Edward
Lauer, Peter
Metchette, Ken
Burdette, Dara
Diner, Elie
Fu, Juan
Soares, Kevin
Brockstedt, Dirk
Portnoy, Daniel
Vance, Russell
Kim, Young
Jaffee, Elizabeth
Pardoll, Drew
Dubensky, Thomas
Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
title Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
title_full Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
title_fullStr Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
title_full_unstemmed Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
title_short Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
title_sort modified sting-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990975/
http://dx.doi.org/10.1186/2051-1426-1-S1-O20
work_keys_str_mv AT leongmeredith modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT kannedavid modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT glickmanlaura modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT lemmensedward modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT lauerpeter modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT metchetteken modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT burdettedara modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT dinerelie modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT fujuan modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT soareskevin modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT brockstedtdirk modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT portnoydaniel modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT vancerussell modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT kimyoung modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT jaffeeelizabeth modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT pardolldrew modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines
AT dubenskythomas modifiedstingactivatingcyclicdinucleotidederivativessignificantlyenhancetheantitumoractivityoftherapeuticvaccines